Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice
The modulation of the gut microbiome has been widely suggested as a promising therapeutic strategy for inflammatory bowel disease (IBD). Here, we established a novel probiotic cocktail to investigate its therapeutic role in acute colitis mice. During dextran sulfate sodium (DSS)-induced colitis, the...
Main Authors: | Yefei Zhu, Yu Xu, Xinyue Wang, Leiping Rao, Xuebing Yan, Renyuan Gao, Tongyi Shen, Yuan Zhou, Cheng Kong, Longxiang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.886061/full |
Similar Items
-
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models
by: Francesco Strati, et al.
Published: (2021-02-01) -
The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study
by: Dorota Mańkowska-Wierzbicka, et al.
Published: (2020-08-01) -
Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis
by: Rizwan Ahmad, et al.
Published: (2023-12-01) -
Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
by: Andrea Quagliariello, et al.
Published: (2020-09-01) -
The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders
by: Maafi R. Islam, et al.
Published: (2022-01-01)